Press Releases Year All News2018201720162015 Forty Seven Inc. Reports Third Quarter 2018 Financial Results and Recent Business Highlights November 13, 2018 Forty Seven Inc. to Present at the Credit Suisse 27th Annual Healthcare Conference November 7, 2018 Forty Seven Inc. to Present New Preclinical Data on 5F9 at the 60th American Society of Hematology (ASH) Annual Meeting November 1, 2018 Forty Seven Inc. Announces Publication in The New England Journal of Medicine of 5F9 Phase 1b Clinical Data in Non-Hodgkin’s Lymphoma (NHL) October 31, 2018 Forty Seven Inc. Appoints Leading Experts in Immuno-Oncology to its Scientific Advisory Board (SAB) October 3, 2018 Forty Seven Inc. to Present at the Morgan Stanley 16th Annual Global Healthcare Conference September 6, 2018 Forty Seven Inc. Reports Second Quarter 2018 Financial Results and Recent Business Highlights August 13, 2018 Forty Seven Inc. to Present at the 38th Annual Canaccord Genuity Growth Conference August 2, 2018 Forty Seven Prices Initial Public Offering June 27, 2018 Forty Seven, Inc. Announces Proof-of-Concept Data from Two Clinical Trials of 5F9 In Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphoma June 3, 2018 Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 20
